UTime (WTO) outlined its ongoing exploration in the field of health data analysis, particularly the potential application of artificial intelligence technologies. UTime is developing AI-based algorithm models aimed at performing in-depth analysis of continuous physiological data collected from smart wearable devices such as watches and rings. Current research directions include: building hypertension risk assessment models by integrating multi-parameter data like blood pressure, heart rate, activity and sleep; and conducting trend assessments of users’ cardiovascular system health status by analyzing features such as pulse wave morphology. The company explicitly states that all these AI analysis functions are intended to provide users with health trend insights and risk management references and are not substitutes for professional medical diagnosis.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WTO:
- UTime Limited Launches Innovative Smart Ring for Health Monitoring
- UTime releases smart ring product for health monitoring
- UTime Limited Unveils Smartwatch with Blood Pressure Monitoring
- UTime Limited Announces Extraordinary General Meeting for Share Consolidation
- UTime Limited Announces Strategic Shift with Elderly Care Platform Partnership
